Fulvestrant
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | generic | 2 | SUPPLYING |
| Sagent Pharmaceuticals | generic | 2 | SUPPLYING |
| Avenacy, LLC | unknown | 1 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 1 | SUPPLYING |
| Zydus Lifesciences Limited | generic | 1 | SUPPLYING |
| BluePoint Laboratories | relabeler | 1 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 1 | SUPPLYING |
| Xiromed, LLC | unknown | 1 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 1 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 1 | SUPPLYING |
| Athenex Pharmaceutical Division, LLC. | unknown | 1 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Fulvestrant Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Oncology.
Fulvestrant Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Oncology.
Failed Impurities/Degradation Specifications — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide.
